Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CADL — Candel Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$592,250
+$510,945 QoQ
Shares Held
57,500
+246.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 138 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CADL ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CADL

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $592,250 57,500
2026-03-31 $81,305 16,593
2025-12-31 $417,528 73,899
2025-09-30 $134,186 26,311
2025-06-30 $105,121 20,775
2025-03-31 $76,777 13,589
2024-12-31 $87,858 10,122
2024-09-30 $42,875 6,187
2024-06-30 $39,332 6,344
2024-03-31 $181 115
2023-12-31 $166 113
2023-09-30 $99 108
2023-06-30 $131 104
2023-03-31 $135 100
2022-12-31 $175 98
2022-09-30 $301 96
2022-06-30 $197 61
2021-09-30 $11,425 1,054